GTS Securities’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-124,300
Closed -$12.9M 1771
2024
Q3
$12.9M Buy
124,300
+10,500
+9% +$1.07M 0.03% 404
2024
Q2
$11M Sell
113,800
-15,900
-12% -$1.47M 0.02% 459
2024
Q1
$11.7M Buy
129,700
+300
+0.2% +$25.4K 0.02% 443
2023
Q4
$10.3M Buy
129,400
+62,200
+93% +$4.68M 0.02% 591
2023
Q3
$4.78M Buy
+67,200
New +$5.02M 0.01% 954

Other funds holding CL

GTS Securities's CL Position: Q2 2026 in Review

GTS Securities reduced its Colgate-Palmolive (CL) stake by 68% in Q2 2026, selling an estimated $456K and leaving 2,509 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #1129.

GTS Securities first reported a position in CL in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.98M in Q4 2024. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • GTS Securities held 2,509 shares of Colgate-Palmolive worth $230K as of Q2 2026.
  • GTS Securities sold 5,212 Colgate-Palmolive shares in Q2 2026, an estimated $456K.
  • Colgate-Palmolive made up ﹤0.01% of GTS Securities's portfolio in Q2 2026, its #1129 holding.
  • GTS Securities first reported a position in Colgate-Palmolive in Q2 2023 and has held it in 11 quarters since.
  • GTS Securities's Colgate-Palmolive position peaked at $1.98M in Q4 2024.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.